2 min readTumour Progression Depends on Tumour Microenvironment
Tokyo, Japan — Researchers from Tokyo Medical and Dental University (TMDU) and Niigata University identify a novel mechanism by which tumours progress
Tumour cells constantly interact with the cellular environment they live in, affecting tumor progression and metastasis. In a new study, researchers from Tokyo Medical and Dental University (TMDU) and Niigata University discovered that the proteins transforming growth factor-β (TGF-β) and tumour necrosis factor alpha (TNF-α) promote the development of cancer-associated fibroblasts, which in turn contribute to tumour progression.
Tumour cells live within a specific tumour microenvironment, in which they are surrounded by other cell types, including those comprising blood vessels, cancer-associated fibroblasts (CAFs) and inflammatory cells. The tumour microenvironment consists of a network of molecules that provide structural and biochemical support to all cells. One such molecule is TGF-β, which is known to induce endothelial-mesenchymal transition (EndMT), a process that involves the conversion of endothelial cells, which comprise the inner lining of blood vessels, to CAFs, which modulate the tumour progression.
“We have previously shown that CAFs derived from EndMT promote tumour formation and progression. However, we do not know much about the molecular mechanisms underlying these interactions,” says corresponding author of the study Tetsuro Watabe (TMDU). “The goal of our study was to investigate how the tumour microenvironment contributes to tumour progression.”
To achieve their goal, the researchers focused on the protein TNF-α, a known cytokine secreted by inflammatory cells. Because tumors are often infiltrated by inflammatory cells, the tumour microenvironment contains high levels of TNF-α. To understand the roles of TNF-α in TGF-β-induced EndMT, the researchers treated human endothelial cells with TGF-β, TNF-α, or both. TGF-β robustly induced EndMT as shown through increased expression of various markers of CAFs as well as a transition towards a CAF morphology of the human endothelial cells. However, interestingly enough, TNF-α enhanced the molecular effects of TGF-β.
Because one of the main biological functions of CAFs is to secrete proteins into the tumor microenvironment and induce tumor progression, the researchers next cultured human oral cancer cells in the presence of the proteins secreted from EndMT-derived CAFs. The researchers found that oral cancer cells underwent epithelial-mesenchymal transition (EMT). Since EMT is a hallmark of tumor progression and metastasis, these results demonstrated that the proteins secreted by CAFs contribute to tumor progression. The researchers also found that these effects of CAFs on tumor progression was suppressed by inhibition of TGF-β, suggesting that TGF-β protein secreted from CAFs induced EMT.
“These are striking results that identify a molecular mechanism underlying the role of the tumor microenvironment in tumor biology. We hope that our findings will aid in the development of novel cancer therapies,” says first and co-corresponding author Yasuhiro Yoshimatsu (Niigata University).
Article adapted from a Tokyo Medical and Dental University news release.
Publication: TNF‐α enhances TGF‐β‐induced endothelial‐to‐mesenchymal transition via TGF‐β signal augmentation. Yoshimatsu, Y et al. Cancer Science (May 09, 2020): Click here to view.